rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Russell Schundler

General Counsel

Company insider

Files Form 4 as: General Counsel, Liquidia.

Every Form 4 they filed

In numbers

Trades disclosed
116
Buys
2
Sells
21
Bought
$768K
Sold
$6.7M
Companies
1
Companies where not an officer
0
First trade
29 Mar 2021
Last trade
12 Oct 2026
Last filed
13 Oct 2026

Companies traded

Where they are an officer
LQDA LiquidiaDirector, Officer · Biotechnology · last 12 Oct 20262 buys · 21 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
20Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
12 Oct 2026filed 13 Oct 2026LQDA LiquidiaBiotechnologySEC FORM 4 Sold$390K13,692 at $28.48filing
9 Oct 2026filed 13 Oct 2026LQDA LiquidiaBiotechnologySEC FORM 4 Code M—3,758filing
9 Oct 2026filed 13 Oct 2026LQDA LiquidiaBiotechnologySEC FORM 4 Code M—6,409filing
9 Oct 2026filed 13 Oct 2026LQDA Liquidiaoption or derivative · BiotechnologySEC FORM 4 Code M—3,758 at $0.00filing
9 Oct 2026filed 13 Oct 2026LQDA Liquidiaoption or derivative · BiotechnologySEC FORM 4 Code M—6,409 at $0.00filing
13 Jul 2026filed 14 Jul 2026LQDA LiquidiaBiotechnologySEC FORM 4 Sold$75K1,046 at $71.39filing
13 Jul 2026filed 14 Jul 2026LQDA LiquidiaBiotechnologySEC FORM 4 Sold$979K13,692 at $71.52filing
13 Jul 2026filed 14 Jul 2026LQDA LiquidiaBiotechnologySEC FORM 4 Sold$75K1,046 at $71.39filing
13 Jul 2026filed 14 Jul 2026LQDA LiquidiaBiotechnologySEC FORM 4 Sold$979K13,692 at $71.52filing
10 Jul 2026filed 14 Jul 2026LQDA LiquidiaBiotechnologySEC FORM 4 Code M—3,759filing
10 Jul 2026filed 14 Jul 2026LQDA LiquidiaBiotechnologySEC FORM 4 Code M—6,409filing
10 Jul 2026filed 14 Jul 2026LQDA Liquidiaoption or derivative · BiotechnologySEC FORM 4 Code M—3,759 at $0.00filing
10 Jul 2026filed 14 Jul 2026LQDA Liquidiaoption or derivative · BiotechnologySEC FORM 4 Code M—6,409 at $0.00filing
10 Jul 2026filed 14 Jul 2026LQDA Liquidiaoption or derivative · BiotechnologySEC FORM 4 Code M—3,759 at $0.00filing
10 Jul 2026filed 14 Jul 2026LQDA Liquidiaoption or derivative · BiotechnologySEC FORM 4 Code M—6,409 at $0.00filing
10 Jul 2026filed 14 Jul 2026LQDA LiquidiaBiotechnologySEC FORM 4 Code M—3,759filing
10 Jul 2026filed 14 Jul 2026LQDA LiquidiaBiotechnologySEC FORM 4 Code M—6,409filing
13 Apr 2026filed 14 Apr 2026LQDA LiquidiaBiotechnologySEC FORM 4 Sold$525K13,692 at $38.37filing
13 Apr 2026filed 14 Apr 2026LQDA LiquidiaBiotechnologySEC FORM 4 Sold$525K13,692 at $38.37filing
10 Apr 2026filed 14 Apr 2026LQDA LiquidiaBiotechnologySEC FORM 4 Code M—3,758filing

Sectors

Health Care23

Buys in green, sells in red, by the company’s sector.

Related people

Roger JeffsChief Executive Officer · Chief Executive Officer at Liquidia, filing Form 4 there in the last year
Michael KasetaCFO and COO · CFO and COO at Liquidia, filing Form 4 there in the last year
Jason AdairChief Business Officer · Chief Business Officer at Liquidia, filing Form 4 there in the last year
Scott MoomawChief Commercial Officer · Chief Commercial Officer at Liquidia, filing Form 4 there in the last year
Rajeev SaggarChief Medical Officer · Chief Medical Officer at Liquidia, filing Form 4 there in the last year
Dana BoyleChief Accounting Officer · Also traded LQDA in the last 90 days
Sanjeev KhindriChief Development Officer · Also traded LQDA in the last 90 days
Sarah KreppChief Human Resource Officer · Also traded LQDA in the last 90 days